Childhood Obesity and Eczema: Systematic Review Probes a Growing Immune Link

Two of the most common health problems of childhood—excess body weight and the chronic inflammatory skin condition known as atopic dermatitis—may be more intertwined than many parents and clinicians realize. A systematic review published in the Archives of Dermatological Research by researchers at McMaster University examines the evidence connecting childhood obesity with atopic dermatitis, the most prevalent form of eczema, and asks whether the association holds up when studies from different countries, designs, and populations are placed side by side. The work, led by Mohit Sehjal and supervised by dermatologist Mohannad Abu-Hilal, arrives at a moment when both conditions are climbing in parallel across much of the world, raising the possibility that they are not merely co-occurring epidemics but biologically linked ones.

Atopic dermatitis affects a substantial share of children, often appearing in the first years of life with intensely itchy, inflamed patches on the face, flexures of the arms and legs, and trunk. Its roots lie in a combination of barrier defects in the skin, genetic susceptibility, and dysregulated immune responses dominated by type 2 inflammatory pathways. Obesity, meanwhile, is no longer viewed as a passive state of energy surplus. Adipose tissue actively secretes hormones, cytokines, and signaling lipids that reshape systemic inflammation. The review’s central premise is that these two biological narratives—barrier failure and immune misfiring on one side, metabolically driven low-grade inflammation on the other—may converge in the same child, with measurable consequences for disease risk and severity.

The research team undertook a systematic synthesis of studies that had previously investigated the relationship between body mass index, overweight, obesity, and atopic dermatitis in pediatric populations. Among the key works the reviewers examined were a 2024 national cross-sectional analysis from Korea published in PLoS ONE, which assessed the association between body mass index and atopic dermatitis among adolescents; case-control studies from 2011 and 2023 that compared obesity rates in children with and without the skin condition; a 2015 JAMA Dermatology investigation linking central obesity with high blood pressure in pediatric atopic dermatitis patients; and a 2022 JAMA Dermatology cohort analysis of atopic dermatitis and growth parameters including height, weight, and body mass index in children. By drawing these threads together, the review offers a consolidated view of a literature that has often produced seemingly inconsistent results.

That inconsistency is itself scientifically revealing. Some studies report that children with obesity carry higher odds of developing atopic dermatitis or experience more severe disease, while others find no meaningful relationship—or even signals pointing the opposite way. One frequently cited example in the literature is a Finnish follow-up study of children after infantile bronchiolitis, which found that overweight did not increase asthma risk and might even be associated with lower allergy risk at school age. Such discordance underscores a central challenge: the direction and strength of any obesity–eczema link may depend on how obesity is measured, whether total body mass or central adiposity is the exposure of interest, how atopic dermatitis is defined, and whether the outcome is diagnosis, severity, or persistence of disease.

Measurement issues loom large in this field. Body mass index, the most widely used metric, is a crude proxy that cannot distinguish lean mass from fat mass or capture the distribution of adipose tissue. Yet fat distribution may matter biologically, because visceral or central obesity generates a more pro-inflammatory milieu than subcutaneous fat. The 2015 JAMA Dermatology study highlighted in the review focused specifically on central obesity and found it associated with elevated blood pressure among children with atopic dermatitis, hinting that the metabolic complications of adiposity and the inflammatory burden of eczema may compound one another. Meanwhile, a longitudinal birth cohort analysis of fetal growth, obesity, and atopic disorders in adolescence suggests that early-life growth trajectories could program later allergic risk, adding a developmental dimension that cross-sectional snapshots cannot capture.

Beneath the epidemiology lies a set of plausible mechanistic pathways. Adipocytes release pro-inflammatory adipokines such as leptin, which can amplify T-cell activity, and reduced levels of anti-inflammatory adiponectin, potentially tipping immune balance toward the type 2 skew characteristic of atopic disease. Obesity is also associated with chronic oxidative stress and altered gut microbiome composition, both of which have been implicated in eczema pathogenesis. Mechanical factors may contribute as well: skin folds in children with obesity create warm, moist microenvironments prone to friction and microbial overgrowth, including colonization by Staphylococcus aureus, a well-known trigger of atopic dermatitis flares. Conversely, the relationship could run in reverse, with itchy, sleep-disrupting eczema limiting physical activity and promoting weight gain—a bidirectional dynamic that most observational studies are poorly equipped to disentangle.

The timing question—does obesity precede eczema, follow it, or simply co-develop—remains the critical unresolved issue, and it is precisely where systematic reviews earn their keep. The McMaster team’s synthesis of case-control designs, which enroll children with and without disease and look backward at exposures, alongside cross-sectional surveys that capture a single moment in time, and longitudinal cohorts that track growth and disease over years, provides a map of where the evidence is strongest and where it frays. Their review, published as a research letter, reflects a deliberate effort to distill a sprawling and sometimes contradictory body of work into a form that clinicians and researchers can act upon, rather than adding another single-population data point to an already crowded field.

For pediatricians and dermatologists, the stakes are practical. If excess adiposity genuinely worsens atopic dermatitis risk or severity, then weight management could become an explicit adjunct to eczema care, complementing emollients, topical anti-inflammatory agents, and the newer systemic therapies that have transformed treatment for moderate-to-severe disease. Conversely, if eczema drives inactivity and weight gain, early aggressive control of itch and inflammation might protect against obesity downstream. Either scenario would justify closer monitoring of growth parameters and metabolic health in children with atopic dermatitis, a population in whom the JAMA Dermatology hypertension findings suggest cardiovascular risk factors may already be converging.

The review also exposes the limitations of the current evidence base. Heterogeneous definitions of pediatric obesity, reliance on parent-reported eczema diagnoses in some surveys, confounding by diet, socioeconomic status, and shared environmental triggers, and the scarcity of interventional data all temper the certainty of any conclusion. The authors note that no datasets were generated or analyzed anew in their study, positioning the work squarely as an interpretive synthesis rather than a primary analysis. Future progress, they and others in the field suggest, will depend on large prospective cohorts with objective adiposity measures, standardized eczema phenotyping, and mediation analyses that can test whether weight change causally shifts disease trajectories.

What emerges from this systematic review is neither a simple alarm nor a dismissal, but a call for precision. Childhood obesity and atopic dermatitis are each formidable public health burdens on their own; the possibility that they amplify one another through shared inflammatory, metabolic, and behavioral pathways makes understanding their intersection a priority. As prevalence curves for both conditions continue to rise, studies like this one from the McMaster group provide the evidentiary scaffolding on which the next generation of longitudinal and mechanistic research—and eventually, targeted prevention strategies—can be built.

Subject of Research: The association between childhood obesity and atopic dermatitis in children

Article Title: The association between childhood obesity and atopic dermatitis: a systematic review

Article References: Sehjal, M., Branyiczky, M. K., Akomolafe, E., & Abu-Hilal, M. (2026). The association between childhood obesity and atopic dermatitis: a systematic review. Archives of Dermatological Research, 318(1), Article 427. https://doi.org/10.1007/s00403-026-04874-3

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04874-3

Keywords: childhood obesity, atopic dermatitis, eczema, systematic review, pediatrics, inflammation, body mass index, adipokines, skin barrier, immune dysregulation, metabolic health, dermatology